FDA Approves Biogen’s Drug for Rare Form of ALSnews2023-04-25T17:53:59+00:00April 25th, 2023|The New York Times|
Supreme Court Ensures, for Now, Broad Access to Abortion Pillnews2023-04-22T14:39:23+00:00April 22nd, 2023|The New York Times|
Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Marketnews2023-04-19T20:30:08+00:00April 19th, 2023|The New York Times|
Appeals Court Says Abortion Pill Can Remain Available but Imposes Temporary Restrictionsnews2023-04-13T14:42:18+00:00April 13th, 2023|The New York Times|
After Texas Ruling, Democratic States Move to Stockpile Abortion Pillsnews2023-04-12T14:11:19+00:00April 12th, 2023|The New York Times|
Abortion Pill Ruling: Read Annotated Excerpts From F.D.A. Casenews2023-04-12T02:32:14+00:00April 12th, 2023|The New York Times|
Pfizer CEO and Other Drug Company Leaders Condemn Texas Abortion Pill Rulingnews2023-04-11T11:21:49+00:00April 11th, 2023|The New York Times|
I Worked at the F.D.A. The Abortion Pill Decision Is Dangerous.news2023-04-10T22:55:57+00:00April 10th, 2023|The New York Times|
Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authoritynews2023-04-10T07:00:09+00:00April 10th, 2023|The New York Times|
The Abortion Pill Ruling Is Bad Law, and the Biden Administration Should Fight Itnews2023-04-09T09:00:12+00:00April 9th, 2023|The New York Times|
